A clinical case of the novel coronavirus (COVID-19) reinfection in a health care worker

Abstract

The peculiarities of immune responses to a novel coronavirus infection (COVID-19) and the possibility of reinfection due to the variability of humoral immunity are currently under discussion. This article presents a case of COVID-19 reinfection in a health care worker.

Keywords

COVID-19 / reinfection / humoral immunity

References

[1] Roy S. COVID-19 Reinfection: Myth or Truth? SN Compr Clin Med. 2020:1–4. doi: 10.1007/s42399-020-00335-8

[2] Roy S. COVID-19 Reinfection: Myth or Truth? // SN Compr Clin Med. 2020. P. 1–4. doi: 10.1007/s42399-020-00335-8

[3] Law SK, Leung AWN, Xu C. Is reinfection possible after recovery from COVID-19? Hong Kong Med J. 2020;26(3):264–265.

[4] Law S.K., Leung A.W.N., Xu C. Is reinfection possible after recovery from COVID-19? // Hong Kong Med J. 2020. Vol. 26, N 3. P. 264–265. doi: 10.12809/hkmj208601

[5] Falahi S, Kenarkoohi A. COVID-19 reinfection: prolonged shedding or true reinfection? New Microbes New Infect. 2020;38:100812. doi: 10.1016/j.nmni.2020.100812

[6] Falahi S., Kenarkoohi A. COVID-19 reinfection: prolonged shedding or true reinfection? // New Microbes New Infect. 2020. Vol. 38, N. P. 100812. doi: 10.1016/j.nmni.2020.100812

[7] Khoshkam Z, Aftabi Y, Stenvinkel P, et al. Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection. J Adv Res. 2021; 31:49-60. doi: 10.1016/J.jare.2020.12.013

[8] Khoshkam Z., Aftabi Y., Stenvinkel P., et al. Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection // J Adv Res. 2021. Vol. 31. P. 49–60. doi: 10.1016/j.jare.2020.12.013

[9] Kang H, Wang Y, Tong Z, Liu X. Retest positive for SARS-CoV-2 RNA of “recovered” patients with COVID-19: Persistence, sampling issues, or re-infection? J Med Virol. 2020;92(11):2263–2265.

[10] Kang H., Wang Y., Tong Z., Liu X. Retest positive for SARS-CoV-2 RNA of “recovered” patients with COVID-19: Persistence, sampling issues, or re-infection? // J Med Virol. 2020. Vol. 92, N 11. P. 2263–2265. doi: 10.1002/jmv.26114

[11] SeyedAlinaghi S, Oliaei S, Kianzad S, et al. Reinfection risk of novel coronavirus (COVID-19): A systematic review of current evidence. World J Virol. 2020;9(5):79–90.

[12] SeyedAlinaghi S., Oliaei S., Kianzad S., et al. Reinfection risk of novel coronavirus (COVID-19): A systematic review of current evidence // World J Virol. 2020. Vol. 9, N 5. P. 79–90. doi: 10.5501/wjv.v9.i5.79

[13] Tao W, Wang X, Zhang G, et al. Re-detectable positive SARS-CoV-2 RNA tests in patients who recovered from COVID-19 with intestinal infection. Protein Cell. 2021;12(3):230–235.

[14] Tao W., Wang X., Zhang G., et al. Re-detectable positive SARS-CoV-2 RNA tests in patients who recovered from COVID-19 with intestinal infection // Protein Cell. 2021. Vol. 12, N 3. P. 230–235. doi: 10.1007/s13238-020-00778-8

[15] Wu F, Zhang W, Zhang L, et al. Discontinuation of antiviral drugs may be the reason for recovered COVID-19 patients testing positive again. Br J Hosp Med (Lond). 2020;81(4):1–2.

[16] Wu F., Zhang W., Zhang L., et al. Discontinuation of antiviral drugs may be the reason for recovered COVID-19 patients testing positive again // Br J Hosp Med (Lond). 2020. Vol. 81, N 4. P. 1–2. doi: 10.12968/hmed.2020.0156

[17] Kang H, Wang Y, Tong Z, Liu X. Retest positive for SARS-CoV-2 RNA of “recovered” patients with COVID-19: Persistence, sampling issues, or re-infection? J Med Virol. 2020;92(11):2263–2265.

[18] Kang H., Wang Y., Tong Z., Liu X. Retest positive for SARS-CoV-2 RNA of “recovered” patients with COVID-19: Persistence, sampling issues, or re-infection? // J Med Virol. 2020. Vol. 92, N 11. P. 2263–2265. doi: 10.1002/jmv.26114

[19] Piri SM, Edalatfar M, Shool S, et al. A systematic review on the recurrence of SARS-CoV-2 virus: frequency, risk factors, and possible explanations. Infect Dis (Lond). 2021;(Jan 28):1–10. doi: 10.1080/23744235.2020.1871066

[20] Piri S.M., Edalatfar M., Shool S., et al. A systematic review on the recurrence of SARS-CoV-2 virus: frequency, risk factors, and possible explanations // Infect Dis (Lond). 2021. Jan 28. P. 1–10. doi: 10.1080/23744235.2020.1871066

[21] Alizargar J. Risk of reactivation or reinfection of novel coronavirus (COVID-19). J Formos Med Assoc. 2020;119(6):1123. doi: 10.1016/j.jfma.2020.04.013

[22] Alizargar J. Risk of reactivation or reinfection of novel coronavirus (COVID-19) // J Formos Med Assoc. 2020. Vol. 119, N 6. P. 1123. doi: 10.1016/j.jfma.2020.04.013

[23] Gousseff M, Penot P, Gallay L, et al. Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound? J Infect. 2020;81(5):816–846.

[24] Gousseff M., Penot P., Gallay L., et al. Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound? // J Infect. 2020. Vol. 81, N 5. P. 816–846. doi: 10.1016/j.jinf.2020.06.073

[25] Arafkas M, Khosrawipour T, Kocbach P, et al. Current meta-analysis does not support the possibility of COVID-19 reinfections. J Med Virol. 2021;93(3):1599–1604.

[26] Arafkas M., Khosrawipour T., Kocbach P., et al. Current meta-analysis does not support the possibility of COVID-19 reinfections // J Med Virol. 2021. Vol. 93, N 3. P. 1599–1604. doi: 10.1002/jmv.26496

[27] Madan M, Kunal S. COVID-19 reinfection or relapse: an intriguing dilemma. Clin Rheumatol. 2020;39(11):3189. doi: 10.1007/s10067-020-05427-3

[28] Madan M., Kunal S. COVID-19 reinfection or relapse: an intriguing dilemma // Clin Rheumatol. 2020. Vol. 39, N 11. P. 3189. doi: 10.1007/s10067-020-05427-3

[29] He F, Luo Q, Lei M, et al. Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review. Clin Rheumatol. 2020;39(9):2803–2810.

[30] He F., Luo Q., Lei M., et al. Successful recovery of recurrence of positive SARS-CoV-2 RNA in COVID-19 patient with systemic lupus erythematosus: a case report and review // Clin Rheumatol. 2020. Vol. 39, N 9. P. 2803–2810. doi: 10.1007/s10067-020-05230-0

[31] Jabbari P, Rezaei N. With Risk of Reinfection, Is COVID-19 Here to Stay? Disaster Med Public Health Prep. 2020;14(4):e33. doi: 10.1017/dmp.2020.274

[32] Jabbari P., Rezaei N. With Risk of Reinfection, Is COVID-19 Here to Stay? // Disaster Med Public Health Prep. 2020. Vol. 14, N 4. P. e33. doi: 10.1017/dmp.2020.274

[33] Parry J. Covid-19: Hong Kong scientists report first confirmed case of reinfection. BMJ. 2020;370:m3340. doi: 10.1136/bmj.m3340

[34] Parry J. Covid-19: Hong Kong scientists report first confirmed case of reinfection // BMJ. 2020. Vol. 370, N. P. m3340. doi: 10.1136/bmj.m3340

[35] West J, Everden S, Nikitas N. A case of COVID-19 reinfection in the UK. Clin Med (Lond). 2021;21(1):e52-e53. doi: 10.7861/clinmed.2020-0912

[36] West J., Everden S., Nikitas N. A case of COVID-19 reinfection in the UK // Clin Med (Lond). 2021. Vol. 21, N 1. P. e52-e53. doi: 10.7861/clinmed.2020-0912

[37] Iwasaki A. What reinfections mean for COVID-19. Lancet Infect Dis. 2021;21(1):3–5.

[38] Iwasaki A. What reinfections mean for COVID-19 // Lancet Infect Dis. 2021. Vol. 21, N 1. P. 3–5. doi: 10.1016/s1473-3099(20)30783-0

[39] Nachmias V, Fusman R, Mann S, Koren G. The first case of documented Covid-19 reinfection in Israel. IDCases. 2020;22:e00970. doi: 10.1016/j.idcr.2020.e00970

[40] Nachmias V., Fusman R., Mann S., Koren G. The first case of documented Covid-19 reinfection in Israel // IDCases. 2020. Vol. 22. P. e00970. doi: 10.1016/j.idcr.2020.e00970

[41] Duggan NM, Ludy SM, Shannon BC, et al. Is novel coronavirus 2019 reinfection possible? Interpreting dynamic SARS-CoV-2 test results. Am J Emerg Med. 2021;39:256 e251-256 e253. doi: 10.1016/j.ajem.2020.06.079

[42] Duggan N.M., Ludy S.M., Shannon B.C., et al. Is novel coronavirus 2019 reinfection possible? Interpreting dynamic SARS-CoV-2 test results // Am J Emerg Med. 2021. Vol. 39. P. 256 e251-256 e253. doi: 10.1016/j.ajem.2020.06.079

[43] Bonifacio LP, Pereira APS, Araujo D, et al. Are SARS-CoV-2 reinfection and Covid-19 recurrence possible? a case report from Brazil. Rev Soc Bras Med Trop. 2020;53:e20200619. doi: 10.1590/0037-8682-0619-2020

[44] Bonifacio L.P., Pereira A.P.S., Araujo D., et al. Are SARS-CoV-2 reinfection and Covid-19 recurrence possible? a case report from Brazil // Rev Soc Bras Med Trop. 2020. Vol. 53. P. e20200619. doi: 10.1590/0037-8682-0619-2020

[45] Pal R, Banerjee M. Are people with uncontrolled diabetes mellitus at high risk of reinfections with COVID-19? Prim Care Diabetes. 2021;15(1):18–20.

[46] Pal R., Banerjee M. Are people with uncontrolled diabetes mellitus at high risk of reinfections with COVID-19? // Prim Care Diabetes. 2021. Vol. 15, N 1. P. 18–20. doi: 10.1016/j.pcd.2020.08.002

[47] Torres DA, Ribeiro L, Riello A, et al. Reinfection of COVID-19 after 3 months with a distinct and more aggressive clinical presentation: Case report. J Med Virol. 2021;93(4):1857–1859.

[48] Torres D.A., Ribeiro L., Riello A., et al. Reinfection of COVID-19 after 3 months with a distinct and more aggressive clinical presentation: Case report // J Med Virol. 2021. Vol. 93, N 4. P. 1857–1859. doi: 10.1002/jmv.26637

[49] Azam M, Sulistiana R, Ratnawati M, et al. Recurrent SARS-CoV-2 RNA positivity after COVID-19: a systematic review and meta-analysis. Sci Rep. 2020;10(1):20692. doi: 10.1038/s41598-020-77739-y

[50] Azam M., Sulistiana R., Ratnawati M., et al. Recurrent SARS-CoV-2 RNA positivity after COVID-19: a systematic review and meta-analysis // Sci Rep. 2020. Vol. 10, N 1. P. 20692. doi: 10.1038/s41598-020-77739-y

RIGHTS & PERMISSIONS

Eco-Vector